Zymergen Raises $500 million IPO

Zymergen raised $500M in IPO financing led by Various, with participation from Various (IPO). AI-powered biofoundry for material and chemical discovery. The new capital is framed around Launch Hyaline electronic film product and scale biofoundry platform.

What it does

AI-powered biofoundry for material and chemical discovery. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

Automated lab runs 10,000 experiments/week; AI identifies winning compounds. Management framed the new capital around Launch Hyaline electronic film product and scale biofoundry platform.

Trend impact

AI biofoundry automating biological discovery for materials and chemicals. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.

Funding history

• April 1, 2021 · IPO · $500 million · Various (IPO)
• October 1, 2021 · Growth Round · $300 million · SoftBank

Products & services

• IPO Tracker capability
• Endpoints News. IPO Tracker capability
• Endpoints News capability
• Endpoints News Nineteen alum-founded unicorns that may have already capability
• McKinsey & Company. Nineteen alum-founded unicorns that may have capability